Business / Finance

RSS

Invacare first quarter earnings per share increases 156% to $0.23

Invacare Corporation today announced its financial results for the quarter ended March 31, 2011.

28 Apr 2011

Aetna first quarter operating earnings is $560.2 million for 2011

Aetna today announced first-quarter 2011 operating earnings of $560.2 million, or $1.43 per share, a per share increase of 46 percent over 2010.

28 Apr 2011

AVEO reports total revenue of $133.6 million for first quarter 2011

AVEO Pharmaceuticals, Inc. today reviewed key first quarter accomplishments and reported consolidated financial results for the first quarter of 2011.

28 Apr 2011

Aetna enters agreement to procure Prodigy Health Group

Aetna today announced that it has entered into an agreement to acquire Prodigy Health Group, the nation's largest independent third party administrator of self-funded health care plans.

28 Apr 2011

Northstar Healthcare acquires ownership interests in Texas based radiation therapy cancer treatment centers

Northstar Healthcare Inc. today announced that it entered into an agreement to acquire certain ownership interests in four physician owned radiation therapy cancer treatment centers from Dr. Chris Phan, a radiation oncologist. Dr. Phan is founder and Chief Executive Officer of Expert Oncology Network Solutions, LLC (EONS). EONS has been instrumental in developing and consulting with cancer centers across Texas.

28 Apr 2011

Novo Nordisk first quarter net profit increases 23% to DKK 4,073 million

Novo Nordisk has completed a pre-specified meta-analysis based on the Degludec phase 3a trial programme. The meta-analysis confirmed that Degludec is associated with a lower risk of hypoglycaemia compared to insulin glargine, both on the total number of confirmed hypoglycaemic events, and on the number of confirmed nocturnal hypoglycaemic events. Both findings are statistically significant.

From Novo Nordisk 28 Apr 2011

Global Health Partner revenues increase 27% to SEK 178.9 million

Global Health Partner: FIRST QUARTER 2011. Revenues increased by 27 percent to SEK 178.9 million.

28 Apr 2011

Cell Therapeutics to sell $16.0 million of shares of Series 12 Preferred Stock and warrants

Cell Therapeutics, Inc. today announced that it has entered into an agreement to sell, subject to customary closing conditions, approximately $16.0 million of shares of its Series 12 Preferred Stock and warrants to purchase shares of its common stock in a registered offering to three institutional investors.

28 Apr 2011

Affymetrix reports total revenue of $73.7 million for first quarter 2011

Affymetrix, Inc., today reported its operating results for the first quarter of 2011. Total revenue for the quarter was $73.7 million, as compared to total revenue of $80.2 million in the first quarter of 2010.

28 Apr 2011

Neovasc 2010 consolidated net loss decreases to $2,630,885

Neovasc Inc., today announced financial results for the year ended December 31, 2010.

27 Apr 2011

Merck board approves additional $5 billion share repurchase program

Merck, known as MSD outside the United States and Canada, today announced that its Board of Directors has approved additional purchases of up to $5 billion of Merck's common stock for its treasury. The treasury stock purchase has no time limit and will be made over time on the open market, in block transactions or in privately negotiated transactions.

27 Apr 2011

ProtoKinetix, Imaginative Research Associates partner to formulate topical anti-inflammation product

ProtoKinetix, is pleased to announce, that it has entered into a Joint Venture Agreement with Imaginative Research Associates, Inc. to formulate a topical anti-inflammation product for the skin care market.

27 Apr 2011

Corning first quarter sales increase 24% to $1.9 billion

Corning Incorporated today announced its results for the first quarter of 2011.

27 Apr 2011

Mastech first quarter revenue increases 27% to $19.9 million

Mastech Holdings, Inc., a national provider of Information Technology and Specialized Healthcare staffing services, announced today its financial results for the first quarter ended March 31, 2011.

27 Apr 2011

Getinge Group net sales decrease 6.0% to SEK 5,241 for first quarter 2011

Getinge Group: Reporting period January - March.

27 Apr 2011

Spectranetics revenue increases 5% to $30.4 million for first quarter 2011

Spectranetics Corporation today reported financial results for the quarter ended March 31, 2011.

27 Apr 2011

Watson reports net revenue of $876.5 million for first quarter 2011

Watson Pharmaceuticals, Inc. today reported net revenue of $876.5 million for the first quarter ended March 31, 2011, compared to $856.5 million in the first quarter 2010.

27 Apr 2011

Thermo Fisher revenues increase 4% to $2.72 billion for first quarter 2011

Thermo Fisher Scientific Inc., the world leader in serving science, today reported its financial results for the first quarter ended April 2, 2011.

From Thermo Fisher Scientific Inc. 27 Apr 2011

JumpStart Ventures invests $250,000 in SPR Therapeutics

JumpStart Ventures, a nonprofit that invests in and partners with innovative, early-stage companies in Northeast Ohio, announced an investment commitment of $250,000 in SPR Therapeutics.

27 Apr 2011

Wolters Kluwer Health enters agreement to acquire Lexi-Comp

Wolters Kluwer Health, a leading provider of information and business intelligence for professionals, students and institutions in medicine, nursing, allied health and pharmacy, today announced that it has entered into an agreement to acquire Lexi-Comp, Inc., a leading global provider of drug information and clinical content for pharmacists and clinicians.

27 Apr 2011